Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia

British Journal of Haematology(2025)10.1111/bjh.70171Source: DataRank Database

MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia is a research paper published in British Journal of Haematology (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.18)OA: greenTopics (47)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Guojun Tang ORCID,Eitan Kugler ORCID,Jennifer Croden ORCID,Koji Sasaki ORCID,Alexandre Bazinet ORCID

Live enrichment

PubMed:40983567 PMC:PMC12490727 OpenAlex:https://openalex.org/W4414445576

National Institutes of Health

Grant: CA100632

NCI NIH HHS

Grant: P30 CA016672

NCI NIH HHS

Grant: P50 CA100632

FWCI

3.18

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12490727/

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.70171

journalhttps://doi.org/10.1111/bjh.70171

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40983567

Fields of Study

Acute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, AcuteMaleFemaleMiddle AgedAdultAgedOncogene Proteins, FusionBone MarrowYoung AdultAged, 80 and overAdolescentBlast CrisisGene RearrangementTreatment Outcome

MeSH Terms

AdolescentAdultAgedAged, 80 and overBlast CrisisBone MarrowFemaleHumansMaleMiddle AgedGene RearrangementLeukemia, Myeloid, AcuteOncogene Proteins, FusionTreatment OutcomeYoung Adult

Keywords

Hazard ratioMyeloid leukaemiaConfidence intervalVenetoclaxChemotherapyBone marrowMyeloidSalvage therapyOverall survivalAMlAtypical MecomInv(3)(q21.3q26.2)T(3;3)(q21.3;q26.2)Variant Mecom